Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): An extension of the STROBE statement

The Lancet Infectious Diseases

Volumn 14, Issue 4, 2014, Pages 341-352

  Field, Nigel ^a   Cohen, Ted ^b   Struelens, Marc J ^c   Palm, Daniel ^c   Cookson, Barry ^d   Glynn, Judith R ^e   Gallo, Valentina ^f   Ramsay, Mary ^d   Sonnenberg, Pam ^a   MacCannell, Duncan ^g   Charlett, Andre ^d   Egger, Matthias ^h   Green, Jonathan ^d   Vineis, Paolo ⁱ   Abubakar, Ibrahim ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^g NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^h UNIVERSITY OF BERN   (Switzerland)

ⁱ IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MOLECULAR MARKER;

ASCERTAINMENT BIAS; CLINICAL ASSESSMENT TOOL; COMMUNICABLE DISEASE; EPIDEMIOLOGICAL DATA; GENETIC VARIABILITY; HEALTH CARE POLICY; HUMAN; INFECTION; INFECTION CONTROL; MOLECULAR CLOCK; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PRIORITY JOURNAL; REVIEW; STRENGTHENING THE REPORTING OF MOLECULAR EPIDEMIOLOGY FOR INFECTIOUS DISEASE; STRENGTHENING THE REPORTING OF OBSERVATIONAL STUDIES IN EPIDEMIOLOGY;

CHECKLIST; COMMUNICABLE DISEASES; EPIDEMIOLOGIC RESEARCH DESIGN; HUMANS; MOLECULAR EPIDEMIOLOGY; RESEARCH DESIGN;

EID: 84896487744     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(13)70324-4     Document Type: Review

References (81)

1. Morand S, Beaudeau F, Cabaret J New frontiers of molecular epidemiology of infectious diseases 2012, Springer, Berlin.
2. Kilbourne ED The molecular epidemiology of influenza. J Infect Dis 1973, 127:478-487.
3. Besser J Use of molecular epidemiology in infectious disease surveillance. Infectious disease surveillance 2008, 393-407. Wiley-Blackwell, Hoboken, NJ. 1st edn. N.M. M'ikanatha, R. Lynfield, C.A. Van Beneden, H. de Valk (Eds.).
4. Traub RJ, Monis PT, Robertson ID Molecular epidemiology: a multidisciplinary approach to understanding parasitic zoonoses. Int J Parasitol 2005, 35:1295-1307.
5. Monis PT, Andrews RH Molecular epidemiology: assumptions and limitations of commonly applied methods. Int J Parasitol 1998, 28:981-987.
6. Mathema B, Kurepina NE, Bifani PJ, Kreiswirth BN Molecular epidemiology of tuberculosis: current insights. Clin Microbiol Rev 2006, 19:658-685.
7. Vineis P, McMichael AJ Bias and confounding in molecular epidemiological studies: special considerations. Carcinogenesis 1998, 19:2063-2067.
8. Ioannidis JPA Molecular bias. Eur J Epidemiol 2005, 20:739-745.
9. Vineis P, Perera F Molecular epidemiology and biomarkers in etiologic cancer research: the new in light of the old. Cancer Epidemiol Biomarkers Prev 2007, 16:1954-1965.
10. Hall A What is molecular epidemiology?. Trop Med Int Health 1996, 1:407-408.
11. Riley LW Molecular epidemiology of infectious disease: principles and practices 2004, ASM Press, Washington, DC.
12. Foxman B, Zhang L, Koopman JS, Manning SD, Marrs CF Choosing an appropriate bacterial typing technique for epidemiologic studies. Epidemiol Perspect Innov 2005, 2:10.
13. Palm D, Johansson A, Ozin A, Friedrich AW, Larsson JT, Struelens MJ Molecular epidemiology of human pathogens: how to translate breakthroughs into public health practice, Stockholm, November 2011. Euro Surveill 2012, 17:2.
14. Köser CU, Holden MTG, Ellington MJ, et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med 2012, 366:2267-2275.
15. Harris SR, Cartwright EJP, Török ME, et al. Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study. Lancet Infect Dis 2013, 13:130-136.
16. Bielaszewska M, Mellmann A, Zhang W, et al. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis 2011, 11:671-676.
17. Rasko DA, Webster DR, Sahl JW, et al. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. N Engl J Med 2011, 365:709-717.
18. Lemey P, Suchard M, Rambaut A Reconstructing the initial global spread of a human influenza pandemic: a Bayesian spatial-temporal model for the global spread of H1N1pdm. PLoS Curr 2009, 1:RRN1031.
19. Porta M, Malats N, Vioque J, et al. Incomplete overlapping of biological, clinical, and environmental information in molecular epidemiological studies: a variety of causes and a cascade of consequences. J Epidemiol Community Health 2002, 56:734-738.
20. Foxman B, Riley L Molecular epidemiology: focus on infection. Am J Epidemiol 2001, 153:1135-1141.
21. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 2007, 4:e296. the STROBE Initiative.
22. Glynn JR, Vynnycky E, Fine PEM Influence of sampling on estimates of clustering and recent transmission of Mycobacterium tuberculosis derived from DNA fingerprinting techniques. Am J Epidemiol 1999, 149:366-371.
23. Comas I, Homolka S, Niemann S, Gagneux S Genotyping of genetically monomorphic bacteria: DNA sequencing in Mycobacterium tuberculosis highlights the limitations of current methodologies. PLoS One 2009, 4:e7815.
24. Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol 2010, 63:e1-37. the Consolidated Standards of Reporting Trials Group.
25. Stone SP, Cooper BS, Kibbler CC, et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. J Antimicrob Chemother 2007, 59:833-840.
26. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 2007, 4:e297. the STROBE Initiative.
27. Little J, Higgins JPT, Ioannidis JPA, et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement. Eur J Epidemiol 2009, 24:37-55.
28. von Elm E, Moher D, Little J Reporting genetic association studies: the STREGA statement. Lancet 2009, 374:98-100. for the STREGA collaboration.
29. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM Reporting recommendations for tumor MARKer prognostic studies (REMARK). Nat Clin Pract Oncol 2005, 2:416-422. the Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics.
30. Gallo V, Egger M, McCormack V, et al. STrengthening the Reporting of OBservational studies in Epidemiology-Molecular Epidemiology (STROBE-ME): an extension of the STROBE Statement. PLoS Med 2011, 8:e1001117. the STROBE Statement.
31. van Belkum A, Tassios PT, Dijkshoorn L, et al. Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect 2007, 13(suppl 3):1-46. the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group on Epidemiological Markers (ESGEM).
32. Lowe HJ, Barnett GO Understanding and using the medical subject headings (MeSH) vocabulary to perform literature searches. JAMA 1994, 271:1103-1108.
33. O'Rourke A, Booth A, Ford N Another fine MeSH: clinical medicine meets information science. J Inf Sci 1999, 25:275-281.
34. Featherstone DA, Rota PA, Icenogle J, et al. Expansion of the global measles and rubella laboratory network 2005-09. J Infect Dis 2011, 204(suppl 1):S491-S498.
35. Manual for the laboratory diagnosis of measles and rubella virus infection, 2nd ed. WHO, (accessed Nov 12, 2013). http://www.who.int/ihr/elibrary/manual_diagn_lab_mea_rub_en.pdf.
36. Balmer O, Tanner M Prevalence and implications of multiple-strain infections. Lancet Infect Dis 2011, 11:868-878.
37. de Roode JC, Pansini R, Cheesman SJ, et al. Virulence and competitive ability in genetically diverse malaria infections. Proc Natl Acad Sci USA 2005, 102:7624-7628.
38. Turner CMR, Aslam N, Dye C Replication, differentiation, growth and the virulence of Trypanosoma brucei infections. Parasitology 1995, 111:289-300.
39. Anderson RM The pandemic of antibiotic resistance. Nat Med 1999, 5:147-149.
40. Vogel U, Morelli G, Zurth K, et al. Necessity of molecular techniques to distinguish between Neisseria meningitidis strains isolated from patients with meningococcal disease and from their healthy contacts. J Clin Microbiol 1998, 36:2465-2470.
41. Andersson MI, Low N, Irish CJ, et al. Molecular epidemiology of a large community-based outbreak of hepatitis B in Bristol, U.K. J Clin Virol 2012, 53:125-129.
42. Chaudhuri S, Das S, Chowdhury A, Santra A, Bhattacharya SK, Naik TN Molecular epidemiology of HCV infection among acute and chronic liver disease patients in Kolkata, India. J Clin Virol 2005, 32:38-46.
43. Bromham L, Penny D The modern molecular clock. Nat Rev Genet 2003, 4:216-224.
44. Glynn JR, Bauer J, de Boer AS, et al. Interpreting DNA fingerprint clusters of Mycobacterium tuberculosis. Int J Tuberc Lung Dis 1999, 3:1055-1060. for the European Concerted Action on Molecular Epidemiology and Control of Tuberculosis.
45. Glynn JR, Yates MD, Crampin AC, et al. DNA fingerprint changes in tuberculosis: reinfection, evolution, or laboratory error?. J Infect Dis 2004, 190:1158-1166.
46. Burman WJ, Stone BL, Reves RR, et al. The incidence of false-positive cultures for Mycobacterium tuberculosis. Am J Respir Crit Care Med 1997, 155:321-326.
47. Guidelines for Australian mycobacteriology laboratories. Commun Dis Intell 2006, 30:116-128. National Tuberculosis Advisory Committee.
48. Murray M Sampling bias in the molecular epidemiology of tuberculosis. Emerg Infect Dis 2002, 8:363-369.
49. Bialek SR, George PA, Xia G-L, et al. Use of molecular epidemiology to confirm a multistate outbreak of hepatitis A caused by consumption of oysters. Clin Infect Dis 2007, 44:838-840.
50. Pfaller MA, Acar J, Jones RN, Verhoef J, Turnidge J, Sader HS Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program. Clin Infect Dis 2001, 32(suppl 2):S156-S167.
51. Ross SA, Novak Z, Pati S, et al. Mixed infection and strain diversity in congenital cytomegalovirus infection. J Infect Dis 2011, 204:1003-1007.
52. Wang W-K, Lin S-R, Lee C-M, King C-C, Chang S-C Dengue type 3 virus in plasma is a population of closely related genomes: quasispecies. J Virol 2002, 76:4662-4665.
53. Chin-inmanu K, Suttitheptumrong A, Sangsrakru D, et al. Feasibility of using 454 pyrosequencing for studying quasispecies of the whole dengue viral genome. BMC Genomics 2012, 13(suppl 7):S7.
54. Supply P, Magdalena J, Himpens S, Locht C Identification of novel intergenic repetitive units in a mycobacterial two-component system operon. Mol Microbiol 1997, 26:991-1003.
55. Kamerbeek J, Schouls L, Kolk A, et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997, 35:907-914.
56. Lazzarini LCO, Rosenfeld J, Huard RC, et al. Mycobacterium tuberculosis spoligotypes that may derive from mixed strain infections are revealed by a novel computational approach. Infect Genet Evol 2012, 12:798-806.
57. Cohen T, van Helden PD, Wilson D, et al. Mixed-strain Mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control. Clin Microbiol Rev 2012, 25:708-719.
58. Morin PA, Luikart G, Wayne RK SNPs in ecology, evolution and conservation. Trends Ecol Evol 2004, 19:208-216. for the SNP workshop group.
59. Worobey M Anthrax and the art of war (against ascertainment bias). Heredity (Edinb) 2005, 94:459-460.
60. Alland D, Whittam TS, Murray MB, et al. Modeling bacterial evolution with comparative-genome-based marker systems: application to Mycobacterium tuberculosis evolution and pathogenesis. J Bacteriol 2003, 185:3392-3399.
61. Pearson T, Busch JD, Ravel J, et al. Phylogenetic discovery bias in Bacillus anthracis using single-nucleotide polymorphisms from whole-genome sequencing. Proc Natl Acad Sci USA 2004, 101:13536-13541.
62. Bonassi S, Au WW Biomarkers in molecular epidemiology studies for health risk prediction. Mutat Res 2002, 511:73-86.
63. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 2004, 96:434-442.
64. Murray M, Alland D Methodological problems in the molecular epidemiology of tuberculosis. Am J Epidemiol 2002, 155:565-571.
65. Borgdorff MW, van den Hof S, Kalisvaart N, Kremer K, van Soolingen D Influence of sampling on clustering and associations with risk factors in the molecular epidemiology of tuberculosis. Am J Epidemiol 2011, 174:243-251.
66. Alland D, Kalkut GE, Moss AR, et al. Transmission of tuberculosis in New York City: an analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994, 330:1710-1716.
67. Houben RMGJ, Glynn JR A systematic review and meta-analysis of molecular epidemiological studies of tuberculosis: development of a new tool to aid interpretation. Trop Med Int Health 2009, 14:892-909.
68. Braden CR, Templeton GL, Cave MD, et al. Interpretation of restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from a state with a large rural population. J Infect Dis 1997, 175:1446-1452.
69. Chua T, Moore CL, Perri MB, et al. Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit. J Clin Microbiol 2008, 46:2345-2352.
70. Foxman B Molecular tools and infectious disease epidemiology 2012, Academic Press, San Diego, CA.
71. Bernard EJ, Azad Y, Vandamme AM, Weait M, Geretti AM HIV forensics: pitfalls and acceptable standards in the use of phylogenetic analysis as evidence in criminal investigations of HIV transmission. HIV Med 2007, 8:382-387.
72. Scaduto DI, Brown JM, Haaland WC, Zwickl DJ, Hillis DM, Metzker ML Source identification in two criminal cases using phylogenetic analysis of HIV-1 DNA sequences. Proc Natl Acad Sci USA 2010, 107:21242-21247.
73. Abecasis AB, Geretti AM, Albert J, Power L, Weait M, Vandamme A-M Science in court: the myth of HIV fingerprinting. Lancet Infect Dis 2011, 11:78-79.
74. Albert J, Wahlberg J, Leitner T, Escanilla D, Uhlén M Analysis of a rape case by direct sequencing of the human immunodeficiency virus type 1 pol and gag genes. J Virol 1994, 68:5918-5924.
75. Beauchamp TL, Childress JF Principles of biomedical ethics 2001, Oxford University Press, Oxford. 5th edn.
76. Policy brief: criminalization of HIV transmission UNAIDS, (accessed Nov 12, 2013). http://data.unaids.org/pub/basedocument/2008/20080731_jc1513_policy_criminalization_en.pdf.
77. Chalmers J The criminalization of HIV transmission. Sex Transm Infect 2002, 78:448-451.
78. Mohanty K The first case of criminalization of transmission of hepatitis B in the UK: defendant sentenced to two years' imprisonment on the grounds of hepatitis B deoxyribonucleic acid sequencing. Int J STD AIDS 2009, 20:587-589.
79. Gurnham D What role should criminal justice play in the fight against STIs?. Sex Transm Infect 2012, 88:4-5.
80. Lévesque E, Joly Y, Simard J Return of research results: general principles and international perspectives. J Law Med Ethics 2011, 39:583-592.
81. Cobo E, Cortés J, Ribera JM, et al. Effect of using reporting guidelines during peer review on quality of final manuscripts submitted to a biomedical journal: masked randomised trial. BMJ 2011, 343:d6783.